Kelu Zhou

1.9k total citations
35 papers, 1.5k citations indexed

About

Kelu Zhou is a scholar working on Molecular Biology, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kelu Zhou has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 22 papers in Ophthalmology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kelu Zhou's work include Retinal Diseases and Treatments (20 papers), Peroxisome Proliferator-Activated Receptors (8 papers) and Wnt/β-catenin signaling in development and cancer (7 papers). Kelu Zhou is often cited by papers focused on Retinal Diseases and Treatments (20 papers), Peroxisome Proliferator-Activated Receptors (8 papers) and Wnt/β-catenin signaling in development and cancer (7 papers). Kelu Zhou collaborates with scholars based in United States, China and France. Kelu Zhou's co-authors include Jian‐xing Ma, Yang Hu, Ying Chen, Fangfang Qiu, Ti Zhou, Bin Zhang, Kyoungmin Park, Yusuke Takahashi, Guoquan Gao and Timothy J. Lyons and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Diabetes.

In The Last Decade

Kelu Zhou

33 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelu Zhou United States 23 872 684 303 219 143 35 1.5k
Haibin Tian China 23 651 0.7× 397 0.6× 214 0.7× 156 0.7× 97 0.7× 79 1.4k
Yan Luo China 23 962 1.1× 566 0.8× 343 1.1× 206 0.9× 67 0.5× 87 1.8k
Sara Rezzola Italy 22 764 0.9× 647 0.9× 312 1.0× 207 0.9× 107 0.7× 42 1.5k
Frederick Pfister Germany 21 593 0.7× 497 0.7× 267 0.9× 101 0.5× 134 0.9× 43 1.8k
Nathan M. Krah United States 17 1.1k 1.3× 880 1.3× 672 2.2× 260 1.2× 57 0.4× 21 2.2k
V. Poulaki United States 17 735 0.8× 277 0.4× 192 0.6× 291 1.3× 121 0.8× 34 1.3k
Shoujian Wang United States 25 772 0.9× 685 1.0× 440 1.5× 116 0.5× 35 0.2× 50 1.4k
Émilie Picard France 23 923 1.1× 725 1.1× 356 1.2× 171 0.8× 48 0.3× 58 2.1k
Chi‐Hsiu Liu United States 20 667 0.8× 534 0.8× 306 1.0× 173 0.8× 29 0.2× 29 1.2k
Christine Spee United States 35 2.0k 2.3× 1.5k 2.2× 844 2.8× 197 0.9× 107 0.7× 83 3.0k

Countries citing papers authored by Kelu Zhou

Since Specialization
Citations

This map shows the geographic impact of Kelu Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelu Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelu Zhou more than expected).

Fields of papers citing papers by Kelu Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelu Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelu Zhou. The network helps show where Kelu Zhou may publish in the future.

Co-authorship network of co-authors of Kelu Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Kelu Zhou. A scholar is included among the top collaborators of Kelu Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelu Zhou. Kelu Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cui, Yi, Kelu Zhou, Rui Cheng, et al.. (2025). Sustained release of a novel non-fibrate PPARα agonist from microparticles for neuroprotection in murine models of age-related macular degeneration. Journal of Controlled Release. 380. 910–926. 1 indexed citations
2.
Qu, Qiang, Kyoungmin Park, Kelu Zhou, et al.. (2022). Sustained therapeutic effect of an anti-inflammatory peptide encapsulated in nanoparticles on ocular vascular leakage in diabetic retinopathy. Frontiers in Cell and Developmental Biology. 10. 1049678–1049678. 9 indexed citations
3.
Qiu, Fangfang, Xiang Ma, Jianglei Chen, et al.. (2020). Pathogenic role of human C-reactive protein in diabetic retinopathy. Clinical Science. 134(13). 1613–1629. 26 indexed citations
4.
Qiu, Fangfang, Kelu Zhou, Rui Cheng, et al.. (2020). Pathogenic Role of PPARα Downregulation in Corneal Nerve Degeneration and Impaired Corneal Sensitivity in Diabetes. Diabetes. 69(6). 1279–1291. 29 indexed citations
5.
Qiu, Fangfang, Tuo Meng, Qian Chen, et al.. (2019). Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration. Molecular Pharmaceutics. 16(5). 1958–1970. 96 indexed citations
6.
Shao, Yan, Jianglei Chen, Lijie Dong, et al.. (2019). A Protective Effect of PPARα in Endothelial Progenitor Cells Through Regulating Metabolism. Diabetes. 68(11). 2131–2142. 35 indexed citations
7.
Pearsall, Elizabeth, Rui Cheng, Satoshi Matsuzaki, et al.. (2019). Neuroprotective effects of PPARα in retinopathy of type 1 diabetes. PLoS ONE. 14(2). e0208399–e0208399. 35 indexed citations
8.
Qiu, Fangfang, Danyang Chen, Rui Cheng, et al.. (2018). Anti-angiogenic effect of a humanized antibody blocking the Wnt/β-catenin signaling pathway. Microvascular Research. 119. 29–37. 9 indexed citations
9.
McBride, Jeffrey D., Xiaochen Liu, William L. Berry, et al.. (2017). Transgenic expression of a canonical Wnt inhibitor, kallistatin, is associated with decreased circulating CD19+ B lymphocytes in the peripheral blood. International Journal of Hematology. 105(6). 748–757. 6 indexed citations
10.
Pearsall, Elizabeth, Rui Cheng, Kelu Zhou, et al.. (2017). PPARα is essential for retinal lipid metabolism and neuronal survival. BMC Biology. 15(1). 113–113. 42 indexed citations
11.
Moran, Elizabeth, Rui Cheng, Kelu Zhou, et al.. (2017). Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. 58(12). 5030–5030. 31 indexed citations
12.
Browne, S., Elizabeth Moran, Fangfang Qiu, et al.. (2016). sFlt Multivalent Conjugates Inhibit Angiogenesis and Improve Half-Life In Vivo. PLoS ONE. 11(6). e0155990–e0155990. 8 indexed citations
13.
Zhou, Kelu, Siribhinya Benyajati, Yun Le, et al.. (2014). Interruption of Wnt Signaling in Müller Cells Ameliorates Ischemia-Induced Retinal Neovascularization. PLoS ONE. 9(10). e108454–e108454. 25 indexed citations
14.
Murray, Anne R., Qian Chen, Yusuke Takahashi, et al.. (2013). MicroRNA-200b Downregulates Oxidation Resistance 1 (Oxr1) Expression in the Retina of Type 1 Diabetes Model. Investigative Ophthalmology & Visual Science. 54(3). 1689–1689. 84 indexed citations
15.
Chen, Ying, Yang Hu, Robert Mott, et al.. (2011). Mechanisms for the Therapeutic Effect of Fenofibrate on Diabetic Retinopathy in Type 1 Diabetes Models. Investigative Ophthalmology & Visual Science. 52(14). 2100–2100. 1 indexed citations
16.
Park, Kyoungmin, Ji Jin, Yang Hu, Kelu Zhou, & Jian‐xing Ma. (2011). Overexpression of Pigment Epithelium–Derived Factor Inhibits Retinal Inflammation and Neovascularization. American Journal Of Pathology. 178(2). 688–698. 69 indexed citations
17.
Zhou, Kelu, et al.. (2010). Cyp2c8 variant reduce the therapeutic response to thiazolidinediones - a godarts study. Diabetologia. 53. 3 indexed citations
18.
Zhou, Ti, Yang Hu, Ying Chen, et al.. (2010). The Pathogenic Role of the Canonical Wnt Pathway in Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 51(9). 4371–4371. 90 indexed citations
19.
Chen, Ying, Yang Hu, Ti Zhou, et al.. (2009). Activation of the Wnt Pathway Plays a Pathogenic Role in Diabetic Retinopathy in Humans and Animal Models. American Journal Of Pathology. 175(6). 2676–2685. 133 indexed citations
20.
Chen, Ying, et al.. (2009). Photoreceptor degeneration and retinal inflammation induced by very low-density lipoprotein receptor deficiency. Microvascular Research. 78(1). 119–127. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haibin Tian Breakdown of academic impact, for papers by Yan Luo Breakdown of academic impact, for papers by Sara Rezzola Breakdown of academic impact, for papers by Frederick Pfister Breakdown of academic impact, for papers by Nathan M. Krah Breakdown of academic impact, for papers by V. Poulaki Breakdown of academic impact, for papers by Shoujian Wang Breakdown of academic impact, for papers by Émilie Picard Breakdown of academic impact, for papers by Chi‐Hsiu Liu Breakdown of academic impact, for papers by Christine Spee
Rankless by CCL
2026